• RNAPII Degradation Drives Chromatin Reorganization in Oocyte

  2026-05-21

  The referenced study uncovers that degradation of RNA polymerase II (RNAPII), rather than simple transcriptional inhibition, is the central mechanism driving the crucial chromatin transition (NSN-to-SN) during mammalian oocyte maturation. This finding revises our understanding of oogenesis and establishes new mechanistic links between transcriptional regulation and developmental competence in preimplantation embryos.

• (S)-(+)-Ibuprofen (SKU B1018): Reliable COX Inhibition in Ce

  2026-05-20

  (S)-(+)-Ibuprofen (SKU B1018) delivers reproducible, selective COX inhibition for cell viability, proliferation, and cytotoxicity assays. This scenario-driven guide addresses experimental pain points, protocol optimization, and product selection—empowering biomedical researchers to achieve robust, data-backed outcomes with confidence.

• TANGO2 Identified as an Acyl-CoA Binding Protein in Mitochon

  2026-05-20

  The reference study establishes TANGO2 as a mitochondrial acyl-CoA binding protein, localizing it within the mitochondrial lumen and linking its dysfunction to metabolic crises in humans. This work clarifies TANGO2's mechanistic role in lipid metabolism, with implications for understanding and modeling metabolic disorders.

• PreScission Protease: Precision HRV 3C Protease for Tag Clea

  2026-05-19

  PreScission Protease (PSP) from APExBIO excels in low-temperature, high-specificity fusion tag removal, uniquely supporting workflows sensitive to protein conformation and activity. Its Gln-Gly site specificity and robust GST fusion protein compatibility empower advanced studies in condensate biology and chromatin research.

• Dual Mitophagy Activation via H2S Axis in Cerebral Ischemia

  2026-05-19

  This study reveals how enriched environmental exposure mitigates cerebral ischemia–reperfusion injury by activating dual mitophagy pathways through a dopamine–H2S signaling axis. By uncovering mitochondrial quality control mechanisms involving both PINK1/parkin and HIF-1α/BNIP3L, the research offers new directions for neuroprotection against stroke-induced oxidative stress.

• EZ Cap™ Human PTEN mRNA: Cap 1-Modified Tumor Suppressor Too

  2026-05-18

  EZ Cap™ Human PTEN mRNA is a Cap 1-modified, poly(A)-tailed mRNA encoding the human PTEN tumor suppressor gene, optimized for high stability and translatability in cancer research and gene therapy. This product enables precise restoration of PTEN function and modulation of PI3K/Akt signaling, filling critical gaps in tumor suppressor gene mRNA delivery strategies.

• Phosbind Acrylamide: Transforming Protein Phosphorylation An

  2026-05-18

  This article unpacks the mechanistic and translational power of Phos binding reagent (Phosbind) acrylamide in advancing protein phosphorylation analysis. By integrating insights from recent TOR signaling research in Neurospora and comparing antibody-free detection strategies, we guide translational researchers toward robust, high-resolution workflows for dissecting dynamic signaling pathways.

• Tin Mesoporphyrin IX: Precision Heme Oxygenase Inhibition Wo

  2026-05-17

  Tin Mesoporphyrin IX (chloride) unlocks nanomolar-precision modulation of heme oxygenase activity for metabolic disease and viral pathogenesis research. This guide details robust experimental workflows, troubleshooting strategies, and practical insights—backed by peer-reviewed evidence and APExBIO’s trusted quality.

• Ribonuclease R (20 U/μL): Enriching Circular RNA with Precis

  2026-05-16

  Ribonuclease R (RNase R) (20 U/μL) from APExBIO enables highly selective degradation of linear RNA, empowering robust circular RNA enrichment for advanced studies in inflammation and DNA damage. Its streamlined protocol, processive specificity, and proven stability make it the gold standard for RNA structure analysis and metabolic pathway dissection.

• 3D Collagen-Based Microtissues: Advancing In Vitro Cancer Mo

  2026-05-15

  This study introduces a modular tissue engineering approach to create 3D collagen-based microtissues that faithfully recapitulate key tumor features, including hypoxia and stemness, and demonstrate clinically relevant drug resistance. The model offers an accessible, reproducible alternative to traditional 2D and 3D cancer culture systems, with direct implications for improving preclinical drug screening and mechanistic studies.

• CAY10499: Inhibitor of Human Hormone Sensitive Lipase in Lip

  2026-05-15

  CAY10499 stands out as a selective, high-potency inhibitor of human hormone sensitive lipase and monoglyceride lipase for advanced lipid metabolism studies. Its robust inhibition profile, compatibility with diverse assay platforms, and proven value in immunometabolic and disease research make it indispensable for precision workflows.

• Reliable PTEN Restoration: EZ Cap™ Human PTEN mRNA in Cancer

  2026-05-14

  Discover how EZ Cap™ Human PTEN mRNA (SKU R1025) addresses core laboratory challenges in cancer research and gene therapy workflows by delivering robust, reproducible, and immune-evasive PTEN expression. This scenario-driven guide reveals best practices and protocol insights for high-fidelity tumor suppressor gene mRNA studies.

• Novel AR Antagonists Target Dimer Interface to Overcome Resi

  2026-05-14

  This study reports the discovery of benzo[b]oxepine-4-carboxamide derivatives as androgen receptor (AR) antagonists that act at the AR dimer interface pocket, rather than the conventional ligand-binding site. The dual-action compound Y5 outperforms standard therapies by both disrupting AR dimerization and inducing AR degradation, providing a promising approach against drug-resistant prostate cancer.

• Artesunate (SKU B3662): Reliable In Vitro Insights for Oncol

  2026-05-13

  This article provides scenario-driven guidance for biomedical researchers evaluating Artesunate (SKU B3662) as an artemisinin derivative in cell viability and cytotoxicity assays. Integrating evidence-backed protocol advice and practical troubleshooting, it demonstrates how high-purity Artesunate from APExBIO delivers reproducibility and confidence in small cell lung and esophageal squamous cell carcinoma workflows.

• MG-262 (Z-Leu-Leu-Leu-B(OH)2): Precision Tools for Ubiquitin

  2026-05-13

  Explore the unique applications of MG-262 (Z-Leu-Leu-Leu-B(OH)2) as a reversible proteasome inhibitor in advanced apoptosis research and cell cycle studies. This in-depth review reveals how nuanced pathway regulation insights shape assay design and experimental interpretation.

16219 records 1/1082 page Next 12345 下5页 Last page